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Abstract 
Background and Purpose: The National Institutes of Health Stroke Scale (NIHSS) correlates 
with presence of large anterior vessel occlusion (LAVO). However, the application of the 
full NIHSS in the prehospital setting to select patients eligible for treatment with 
thrombectomy is limited. Therefore, we aimed to evaluate the prognostic value of simple 
clinical selection strategies.  
Methods: Data from the Safe Implementation of Thrombolysis in Stroke International 
Stroke Thrombolysis Registry (2012-May 2014) were analyzed retrospectively. Patients 
with complete breakdown of NIHSS scores and documented vessel status were included. 
We assessed the association of prehospital stroke scales and NIHSS symptom profiles with 
LAVO (internal carotid artery, carotid-terminus or M1-segment of the middle cerebral 
artery).  
Results: Among 3505 patients, 23.6% (n=827) had LAVO. Pathological finding on the NIHSS 
item ‘best gaze’ was strongly associated with LAVO (adjusted OR 4.5, 95%CI 3.8-5.3). All 
three Face-Arm-Speech Time test (FAST) items identified LAVO with high sensitivity. 
Addition of abnormal ‘gaze’ to FAST (G-FAST) or high scores on other simplified stroke 
scales increased specificity. The NIHSS symptom profiles representing total anterior 
syndromes showed a 10-fold increased likelihood for LAVO compared to a non-specific 
clinical profile. If compared to an NIHSS threshold of >=6, the prehospital stroke scales 
performed similarly or even better without losing sensitivity.   
Conclusions:  Simple modification of the FAST score or evaluating the NIHSS symptom 
profile may help to stratify patients’ risk of LAVO and to identify individuals who deserve 
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rapid transfer to comprehensive stroke centers. Prospective validation in the prehospital 
setting is required. 
 
Introduction 
The beneficial effects of endovascular treatment (EVT) in addition to intravenous 
thrombolysis (IVT) have been proven in patients with acute ischemic stroke caused by 
large anterior vessel occlusion (LAVO).1-5 Given the time-dependent effects of 
revascularization,6,7 rapid recognition of potentially eligible patients for such treatment is 
critical, both in the prehospital and the early in-hospital triage stage. Because EVT and 
complex diagnostic imaging resources often have limited availability outside of 
comprehensive stroke centers (CSC) or clinical trial settings, there is a pressing need to 
develop strategies to identify patients that need bypass of a primary stroke center (PSC) 
and transfer to CSCs with EVT capability. These strategies should balance well between 
sensitivity to capture the majority of LAVO and appropriate specificity to avoid 
overwhelming the CSCs with patients that do not require EVT.  
A high National Institutes of Health Stroke Scale (NIHSS) score is strongly associated with 
presence of LAVO.8-10 Therefore, the NIHSS is frequently recommended to select patients 
for EVT.11,12 Due to the complexity of a complete NIHSS examination, simple stroke 
recognition scores like the Face-Arm-Speech Time (FAST) test are commonly used by 
paramedics to evaluate patients with suspected stroke in the field. Moreover, certain 
NIHSS items or symptom patterns may be more informative of LAVO compared to simply a 
score reflecting the overall severity of deficits. Recently, six profiles of NIHSS symptoms 
have been proposed and shown to improve the clinical value of the overall NIHSS 
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concerning prediction of functional outcome and mortality.13-15 In order to evaluate 
different simple triage strategies beyond the total NIHSS sum score, we aimed to analyze 
the value of the common prehospital stroke scales and the NIHSS item profiles to predict 
LAVO in acute stroke patients. 
 
Methods 
Data source, design, patients, and outcomes 
We conducted a retrospective analysis on individual patient data obtained from the Safe 
Implementation of Thrombolysis in Stroke International Stroke Thrombolysis Registry 
(SITS-ISTR) between January 2012 and May 2014. SITS-ISTR is a multinational open registry 
of acute ischemic stroke patients who received reperfusion therapies.16,17 Patients from 
132 participating centers with complete breakdown of NIHSS scores and status of vessel 
occlusion were included. Baseline characteristics included data on age, sex, stroke severity 
according to the NIHSS, onset-to-treatment time, pre-stroke modified Rankin Scale (mRS), 
and medical history (i.e. previous stroke, current smoking, hypertension, diabetes, atrial 
fibrillation, and chronic heart failure).  
Our outcome of interest was the presence of LAVO (i.e., occlusion within the internal 
carotid artery, carotid-T and M1 segment of the middle cerebral artery). The definition of 
LAVO was in accordance to the recent positive endovascular treatment trials in patients 
with anterior circulation stroke.18,19 Vessel imaging was usually performed before 
treatment with thrombolysis or shortly after application of bolus dose.  
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Two sensitivity analyses were conducted. First, we added basilar artery occlusion (BAO) to 
the definition of large vessel occlusion. Although currently EVT is not covered by Class I 
recommendation in BAO, guidelines recommend clinical evaluation of patients with BAO in 
CSCs.11 Thus, prehospital detection of patients with BAO is important. Second, we confined 
the analysis to patients with moderate stroke severity (NIHSS 6-11). This group constitutes 
a relevant subgroup because most false positive or false negative identifications of LAVO 
occurs and the majority of patients evaluated in the field have overall moderate stroke 
severity. The upper limit of NIHSS 11 was chosen for consistency with optimal cut-off for 
prediction of LAVO in the previous studies.9,20-22 The lower threshold of NIHSS 6 was 
chosen as this cutoff showed at least 90% sensitivity for LAVO in the present cohort and 
previous reports.20,21 Stroke with NIHSS score <6 is often considered mild stroke, with low 
probability of LAVO.23  
 
Common prehospital stroke scales and NIHSS item profiles  
We evaluated prehospital stroke recognition scales that could be derived directly from the 
individual breakdown of NIHSS items at baseline (i.e., Face Arm Speech Time [FAST] test) 
and simplified NIHSS scores that have been shown to be associated with LAVO (i.e., 3-item 
Stroke Scale [3I-SS], the Rapid Arterial Occlusion Evaluation Scale [RACE], the Cincinnati 
Stroke Triage Assessment Tool [C-STAT], and the Prehospital Acute Stroke Severity scale 
[PASS]).24-26 Supplemental Table I summarizes components of the prehospital stroke scales 
that were analyzed. As the NIHSS item ‘best gaze’ is missing in the typical FAST algorithm 
but strongly associated with LAVO,21,26,27 we tested the hypothesis that adding the 
abnormal gaze to FAST (G-FAST) may improve its predictive value.  
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The NIHSS item profiles that were recently described and validated may prove useful for 
clinical stroke prognostication and research studies.13-15 The profiles grouped the 15 
individual attributes of NIHSS, using latent class analysis, into six clinical symptom 
profiles.13-15 We applied the probabilities of profile membership generated by Sucharew et 
al to our cohort. Profile A represents a total anterior circulation syndrome (TACS) of the 
dominant hemisphere, Profile B a TACS of the non-dominant hemisphere, Profile C a 
partial anterior circulation syndrome (PACS) of the dominant hemisphere with 
predominant language deficits, Profile D a PACS of dominant hemisphere without 
predominant language deficits, Profile E a PACS of the non-dominant hemisphere, and 
Profile F a mild clinical syndrome with low probability of abnormal findings on all NIHSS 
items (Supplementary Table II). 
 
Statistical methods 
Continuous variables were compared using the t-test or Mann–Whitney U test and were 
presented as mean± standard deviation (SD) or median (interquartile range, IQR), where 
appropriate. Categorical variables were compared using the Pearson χ2 test and presented 
as percentages (n). Multivariable logistic regression analysis was performed to assess the 
association of single NIHSS items, the prehospital stroke scales, and the NIHSS profiles with 
LAVO. Adjustment was made for variables significantly associated with LAVO in the 
univariable comparison (sex, atrial fibrillation, onset-to-treatment time). We also adjusted 
the analysis for age, pre-stroke mRS >2 (i.e. being dependent from others in activities of 
daily living) and history of previous stroke, because pre-stroke disability and residual 
neurological deficits from a previous stroke may affect the NIHSS. For the prehospital 
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stroke scales, the lowest score was used as the reference. For the NIHSS item profiles, 
profile F (stroke with low probabilities of abnormal findings on all 15 items) was used as 
reference. Regarding single NIHSS items, we applied forward stepwise regression analysis 
to identify the NIHSS item that improves the model most.  
We computed area under the receiver operating characteristics (ROC) curve (AUC) and the 
respective 95% confidence intervals (CI) to assess the global performance of the 
prehospital stroke scales and NIHSS symptom profiles to predict LAVO. AUC values were 
compared using the method of DeLong et al.28 The ROC-derived optimal cut-off for the 
scores was determined at the maximal Youden-Index.29 Finally, we calculated sensitivity, 
specificity, positive predictive value (PPV), negative predictive value (NPV), and overall 
accuracy for the prediction of LAVO, at high-sensitivity (>85%) and high-specificity (>75%) 
cut-offs of the common prehospital stroke scales. For consistency with the sensitivity of 
the widely-accepted FAST and CPSS scores for recognition of stroke patients in the field, a 
sensitivity >85% was considered as the high-sensitivity threshold.30,31 The target specificity 
of >75% is even higher than the average specificity of common stroke recognition tools to 
discriminate strokes from stroke mimics and suggests rate of futile transfers of less than 
one out of four.31,32 Data analysis was performed using SPSS (version 22, IBM, New York, 
USA) or MedCalc (Version 16.2, Ostend, Belgium). 
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Results 
During the study period, 3505 patients with complete breakdown of NIHSS items and data 
on vessel occlusion site were available for analysis. LAVO was present in 23.6% (n=827) of 
patients. Baseline characteristics of patients with or without LAVO are shown in Table 1. 
Baseline NIHSS was strongly associated with LAVO (adjusted OR 1.15, 95%CI 1.13-1.16, per 
point). Sensitivity, specificity, PPV and NPV at different NIHSS cut-offs are shown in 
supplemental table III.  
As shown in Table 2, there was a graded relationship between prehospital stroke scales 
scores and NIHSS item profiles with presence of LAVO. Compared to a FAST score of 0 or 1, 
patients with all three FAST items being positive had an adjusted OR of 7.9 (95% CI 5.2-
11.9) for LAVO (sensitivity 84%, specificity 44%, PPV 32%, NPV 90%). Forward stepwise 
multiple regression analysis suggested ‘best gaze’ to be the single NIHSS item with 
strongest association with LAVO (adjusted OR 4.5, 95% CI 3.8-5.3). Addition of ‘abnormal 
gaze’ to FAST improved specificity (table 2) and resulted in significant improvement of the 
AUC for LAVO compared to FAST alone (p<0.001, supplemental table IV). 
The six NIHSS symptom profiles that represent different clinical phenotypes were 
reproduced from previous analyses.13-15 Patients allocated to NIHSS symptom profiles 
representing TACS (profile A and B) had a more than 6-fold increased of LAVO compared 
to all other profiles combined (OR 6.2, 95%CI 5.1-7.5). 
Table 3 shows sensitivity, specificity, PPV and NPV for presence of LAVO of different cut-
offs of the entire NIHSS, the prehospital stroke scales and NIHSS item profiles. High 
sensitivity was observed for FAST>=2, G-FAST >=3, C-STAT >=1, 3I-SS >=1, PASS>=1, RACE 
>=3 and clinical signs of at least a PACS (NIHSS symptom profiles A to E), while high 
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specificity was observed for G-FAST=4, C-STAT>=3, 3I-SS=3, PASS=3, RACE >=6 and clinical 
signs of TACS (NIHSS symptom profile A and B).> 
The AUC of the prehospital stroke scales and NIHSS item profiles to predict LAVO was 
similar and nearly as good as the entire NIHSS (supplemental table IV), especially in 
patients presenting with moderate stroke severity. When compared to the NIHSS cut-off 
>=6 which is recommended by current AHA/ASA guidelines to select patients for 
thrombectomy (AUC 0.60, 95%CI 0.58-0.62), AUC of the G-FAST>=3 (AUC 0.64, 95%CI 0.62-
0.66) and C-STAT>=1 (AUC 0.63, 95%CI 0.61-0.65) were significantly higher (p<0.001), but 
the cut-offs showed similar sensitivity (89-91%, table 3). 
 
Sensitivity analyses  
Similar results were obtained after addition of 93 patients with basilar artery occlusion 
(BAO) to the large vessel occlusion definition (n=920, 26.2%), although the overall strength 
of the association was slightly weaker (Supplemental table V). The optimal NIHSS cut-off 
was also >=12 (sensitivity 70%, specificity 70%, PPV 45%, NPV 87%) and the cut-off 
showing at least 85% sensitivity was >=7 (sensitivity 88%, specificity 39%, PPV 34%, NPV 
90%). The optimal cut-offs for detection of LVO including BAO were FAST=3, G-FAST=4, C-
STAT>=2, 3I-SS>=2, and RACE >=5 (supplemental table VI). 
When we focused our analysis to patients with moderate stroke severity (NIHSS 6-11, 
n=1257 patients), frequency of LAVO was 12.6% (19.2% of all observed LAVO within the 
cohort, 159 of 827). The common prehospital stroke scales’ performances for prediction of 
LAVO did not differ from the overall total NIHSS score (supplemental table III), with the 
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highest absolute AUC value for the C-STAT. Similar to the entire cohort,  increasing integer 
values of the common prehospital stroke scales showed disparate associations with LAVO 
(supplemental table VII). Profiles A and B (left and right TACS) were associated with a 
nearly 3-fold increased risk of LAVO compared to all other profiles (C-F combined, adjusted 
OR 2.8, 95%CI 2.0-4.0). 
 
 
Discussion 
One of the major challenges of the current stroke care is to translate the implications of 
the endovascular stroke trials into clinical practice. Non-invasive vessel imaging and rapid 
transfer of eligible patients to CSCs with EVT treatment option need to be organized 
effectively. Since no triage strategy performs perfectly, some patients with LAVO will be 
inevitably missed and many patients without LAVO will be transferred to CSCs.22 It is a 
political issue to decide what range of false negatives and false positives are acceptable 
from the perspective of society as a whole. Local circumstances should also influence the 
choice of selection criteria. 
In general, prehospital triage tools for detection of LAVO should be as simple as possible 
and easily repeatable by EMS staff. In addition, the ideal scores are supposed to 
discriminate stroke patients from stroke mimics. In our cohort, the simple prehospital 
stroke scales performed nearly as well as the entire NIHSS in identifying LAVO, and at least 
as well as the entire NIHSS in patients with overall moderate severity. Importantly, highly 
sensitive cut-offs of the prehospital scores performed as well as or even better than NIHSS 
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cut-off >=6, which is recommended to select patients for thrombectomy according to the 
current AHA/ASA guidelines.12 Thus, our findings emphasize the potential of simplified 
NIHSS scores to detect LAVO in the prehospital setting. Our sensitivity analysis 
demonstrated comparable findings when basilar artery occlusion was included in the large 
vessel occlusion category. 
Several stroke recognition tools have been validated for prehospital evaluation of patients 
with suspected strokes.30-32 The FAST score is already widely used and shows the best 
sensitivity for correct diagnosis of stroke together with the similar CPSS.30,31 In order to 
identify stroke patients with underlying LAVO in the field, it seems reasonable to use a 
two-step screening process starting with the FAST score. FAST has the advantage of using 
the item ‘facial palsy’ that has been shown to be the NIHSS item with best capability to 
discriminate between strokes and mimics.33 In a second step, another tool is needed for 
the triage regarding vessel imaging and facilitate transfer to EVT centers. Ideally, this 
secondary score should be deduced from the initial score but require addition of only a 
few more items with higher sensitivity and specificity for presence of LAVO. In line with 
previous studies,21,27(HASTRUP) we found that gaze deviation was the most sensitive 
clinical sign suggestive of LAVO. Thus, a simple expansion of the typical FAST score by the 
NIHSS item ‘best gaze’ was developed in our study (G-FAST or ‘Go FAST’). G-FAST would 
fulfill the criteria mentioned above and has the advantage of mentioning all tested signs as 
an acronym. The C-STAT follows a similar concept and also seems promising at the second 
stage as cortical signs (especially gaze) strengthen the score, but still it maintains 
simplicity.18 By using the questions and commands from the NIHSS instead of the language 
and speech items which are complex for many emergency medical services, the C-STAT 
makes the rating objective, rather than subjective. Satz ergänzen zu (HASTRUP)?? 
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Importantly, the optimal prehospital triage strategy depends on various time variables. 
Besides time from symptom onset until first evaluation by paramedics, transport time to 
next CSC has to be considered. Our analysis adds relevant findings in at least three 
different clinical scenarios:  
First, we consider a patient with suspected stroke who is evaluated by paramedics early 
after onset of symptoms or with short transfer time to a CSC. In this case, a high sensitivity 
for LAVO (ideally close to 90%) should be achieved. This was observed in different 
symptom combinations in our study, namely: at least two FAST items being positive, all 
three FAST items or abnormal NIHSS item ‘best gaze’, G-FAST >=3, C-STAT >=1, 3I-SS >=1, 
PASS>=1, RACE >=3 and clinical signs of at least a PACS (NIHSS symptom profiles A to E).  
Second, we consider a patient with suspected stroke who is evaluated by paramedics at 
the end of IVT time-window or with long transfer time to the nearest CSC. In this case a 
high specificity (>75%) for LAVO is warranted with less than one out of four futile transfers. 
This was observed for patients with abnormal gaze and all three FAST items being positive 
(G-FAST=4), C-STAT>=3, 3I-SS=3, PASS=3, RACE >=6 and clinical signs of TACS (NIHSS 
symptom profile A and B). 
Third, we consider a patient who arrives at a PSC and is evaluated by trained stroke 
physicians. In this case full examination of the NIHSS is feasible. It has been shown that no 
single variable beyond the NIHSS is able significantly to improve prediction of LAVO.10 
Current recommendations by the European Stroke Organisation are based on the 
statistically optimal NIHSS cut-point observed in the large Bernese stroke registry 
(NIHSS>=9 within 3h, NIHSS>=7 within 6h).8,11 Our findings suggest that lower NIHSS cut-
offs could be used to improve sensitivity (>90% with NIHSS >=6 and >95% with NIHSS >=5). 
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Yet, there are certain constellations in which application of highly specific LAVO scores or 
the highly specific NIHSS symptom profiles A or B could be helpful. Amongst others these 
are: late arrival close to 6 hours, relative contraindications to CT-A like severely impaired 
kidney function or uncontrolled hyperthyroidism, and to avoid expenses of screening 
failures in a randomized controlled trial. 
Although all NIHSS items contribute equally to the sum score, certain items and item 
constellations may reflect larger ischemic lesions that carry a high attributable risk of an 
underlying LAVO. Not surprisingly, we observed a graded association of the NIHSS item 
profiles with LAVO. The two symptom profiles with the highest risks, Profiles A and B, 
represent left and right total hemispheric syndrome, respectively. Thus, our findings 
suggest that patterns of deficit rather than simply scores reflecting severity of deficit will 
be more useful in triage. Although the exact concept of the NIHSS symptom profiles may 
be difficult to conduct by paramedics, our findings support the notion that patients with a 
total anterior clinical syndrome, even if mild to moderate, should prompt an urgent 
neurovascular imaging and consideration for a transfer to a dedicated stroke center 
capable of EVT. Given that right-hemispheric symptoms are under-represented in the 
NIHSS, patients with right LAVO might be missed in case of mild to moderate stroke 
severity based on NIHSS scoring alone.  
Our study has limitations. While the overall extent and accuracy of data collected within 
SITS-ISTR allow for statistically robust analyses, the retrospective and observational design 
inherits potential for bias. Our cohort consists of patients who received revascularization 
treatments after a clinical diagnosis of acute ischemic stroke was already established and 
hemorrhagic stroke was ruled out by brain imaging. Consequently, sensitivity and 
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specificity of the simplified NIHSS scores for LAVO might differ in prehospital cohorts with 
suspected stroke that include stroke mimics and hemorrhagic strokes. Majority of data 
were derived from primary stroke centers with limited availability of vessel-imaging 
compared to comprehensive stroke centers. Moreover, data on LAVO status were 
obtained from assessment by local radiologists at the respective centers (not necessarily 
neuroradiologists). It is reassuring that 96% of patients within the ESCAPE trial had the 
correct target-vessel occlusion status by using similar LAVO definition as per our analysis, 
after review from central adjudication laboratory.2 In addition, it is possible that residual 
deficits related to prior stroke or other reasons may affect baseline NIHSS score, 
consequently led to incorrect ratings. We have accounted for this by adjusting the analysis 
for pre-stroke mRS and previous stroke. Finally, we were not able to evaluate other 
established stroke recognition tools (e.g. LAMS, LAPSS, MASS, ROSIER),31,32 because ‘grip 
strength’ was not part of the NIHSS recording and some scores require additional 
information other than the NIHSS  (e.g. history of seizures).  
In summary, we found that the common simplified NIHSS scores may be useful to stratify 
patients’ risk of LAVO in the prehospital setting. Certain cut-offs were suggested to give 
guidance in clinical settings that require either high sensitivity (>85%) or high specificity 
(>75%). In general, patients with abnormal findings on all three FAST items, and, especially 
patients with additional gaze deviation (G-FAST) may be considered for urgent 
neurovascular imaging and transfer to comprehensive stroke centers. This subset of 
patients may be readily identifiable by paramedics during the prehospital stage. Our 
findings deserve prospective validation, ideally in the prehospital setting. The upcoming 
specialized stroke ambulances seem to be one of the promising settings to validate our 
findings and the feasibility of triage tools.  
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Table 1 - Baseline characteristics of the cohort according to presence of LAVO  
 Entire cohort 
N=3505 
LAVO 
N=827 
No LAVO    
N=2678 
 
p 
Age, years, mean (± SD) 68.1 (±13.6) 68.3 (±13.5) 68.1 (±13.6) 0.631 
Sex, male, % (n) 56.1 (1967) 52.6 (435) 57.2 (1532) 0.020 
Pre-mRS>2, % (n), 164 missings 4.0 (134) 3.7 (29) 4.1 (105) 0.577 
NIHSS sum, median (IQR) 9 (6-16) 16 (11-20) 8 (5-13) <0.001 
Endovascular treatment, % (n) 8.0 (282) 26.6 (220) 2.3 (62) <0.001 
Atrial fibrillation, % (n), 16 missings 18.9 (661) 22.8 (188) 17.7 (473) 0.001 
Chronic Heart Failure, % (n), 21 missings 7.7 (268) 8.6 (71) 7.4 (197) 0.255 
Current Smoker, % (n) , 121 missings 17.5 (593) 18.2 (143) 17.3 (450) 0.560 
Diabetes, % (n) , 13 missings 18.5 (645) 16.9 (139) 19.0 (506) 0.187 
Hyperlipidemia, % (n) , 34 missings 29.6 (1028) 31.5 (257) 29.1 (771) 0.188 
Hypertension, % (n) , 12 missings 64.6 (2258) 64.8 (533) 64.6 (1725) 0.935 
Previous Stroke, % (n) , 20 missings 12.0 (417) 11.1 (91) 12.2 (326) 0.358 
Onset-to-needle, min, median (IQR) 150 (119-195) 145 (115-190) 150 (120-195) 0. 028 
Abbreviations: LAVO – large anterior vessel occlusion, mRS – modified Rankin Scale, NIHSS - National Institutes of Health Stroke Scale 
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Table 2 - Association of NIHSS categories, NIHSS symptom profile, and simplified NIHSS scores with LAVO 
Score name Score result LAVO n/N Number needed 
to screen* 
Adjusted OR for LAVO† 
NIHSS categories 0-5 72/828 11.5 1 (Reference) 
 6-10 128/1107 8.7 1.40 (1.02-1.92) 
 11-15 191/679 3.6 4.29 (3.15-5.83) 
 >15 436/891 2.1 10.72 (8.00-14.37) 
NIHSS symptom profile A 318/793 2.5 10.24 (6.40-16.38) 
 B 310/775 2.5 9.95 (6.22-15.92) 
 C 38/352 9.3 1.85 (1.05-3.25) 
 D 70/644 9.2 1.62 (0.97-2.72) 
 E 68/591 8.7 1.87 (1.12-3.13) 
 F 23/350 15.2 1 (Reference) 
FAST 0 3/63 20.8 1 (Reference) 
 1 25/429 17.2 1.65 (0.38-7.18) 
 2 104/806 7.8 4.19 (1.01-17.45) 
 3 695/2207 3.1 12.29 (2.99-50.57) 
G-FAST‡ 0 3/56 18.6 1 (Reference) 
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 1 22/398 18.2 1.37 (0.31-6.05) 
 2 68/686 10.0 2.85 (0.68-11.99) 
 3 265/1334 5.0 5.96 (1.44-24.68) 
 4 468/1029 2.2 20.52 (4.97-84.99) 
C-STAT 0 92/1091 11.9 1 (Reference) 
 1 145/953 6.6 1.85 (1.38-2.48) 
 2 108/410 3.8 4.17 (3.04-5.74) 
 3 266/606 2.3 8.81 (6.65-11.66) 
 4 216/445 2.1 10.58 (7.82-14.32) 
PASS 0 23/296 12.8 1 (Reference) 
 1 153/1446 9.4 1.38 (0.86-2.24) 
 2 333/1074 3.2 5.63 (3.53-8.97) 
 3 318/689 2.2 11.16 (6.92-18.00) 
RACE 0-1 55/781 14.2 1 (Reference) 
 2 63/587 9.3 1.75 (1.18-2.60) 
 3 55/368 6.7 2.35 (1.54-3.57) 
 4 65/327 5.0 3.42 (2.27-5.14) 
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Abbreviations: 3I-SS - 3-item Stroke Scale, C-STAT - Cincinnati Stroke Triage Assessment Tool, FAST – face, arm, speech and time test, G-FAST – Go FAST score, LAVO – large 
anterior vessel occlusion, NIHSS - National Institutes of Health Stroke Scale, PASS – Prehospital Acute Stroke Severity scale, RACE  - Rapid Arterial Occlusion Evaluation Scale. 
* number needed to screen with the respective test result to identify a LAVO, per 100 patients. † adjusted for age, sex, atrial fibrillation, pre-mRS, prior stroke and onset-to-
treatment time. ‡ In G-FAST the item ‘best gaze’ was added to the FAST score ( G-FAST).§ in contrast to the original version only one point was assigned per pathological item. 
 
 
 
 
 
 
 
 
 5-6 153/590 3.9 4.79 (3.38-6.79) 
 7-9 436/852 2.0 15.18 (10.96-21.02) 
3I-SS§ 0 68/803 11.8 1 (Reference) 
 1 221/1419 6.4 1.90 (1.41-2.56) 
 2 367/900 2.5 7.47 (5.56-10.00) 
 3 171/383 2.2 8.44 (6.03-11.81) 
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Table 3 - Sensitivity, specificity, PPV, and NPV for presence of LAVO at certain cut-offs of the NIHSS, simplified NIHSS scores and NIHSS symptom profiles. 
Cut-offs of scores with >85% sensitivity and highest possible specificity 
 n/N (%) Sensitivity Specificity PPV NPV Accuracy 
NIHSS>=8 2183/3505 (63.2) 85.6 44.9 28.2 91.3 54.5 
NIHSS>=6* 2677/3505 (76.4) 91.3 28.2 28.2 91.3 43.1 
FAST>=2 3013/3505 (86.0) 96.6 17.3 26.5 94.3 36.0 
FAST=3 OR abnormal item ‘Best 
Gaze’ 
2410/3505 (68.8) 89.1 37.5 30.6 91.8 49.7 
G-FAST>=3 2363/3505 (67.5) 88.7 39.1 31.0 91.8 50.8 
C-STAT>=1 2414/3505 (68.9) 88.9 37.3 30.4 91.6 49.5 
3I-SS>=1 2702/3505 (77.1) 91.8 27.5 28.1 91.5 42.7 
PASS >=1 3209/3505 (91.6) 97.2 10.2 25.1 92.2 xx 
RACE>=3 2137/3505 (61.0) 85.7 46.7 33.2 91.4 55.9 
NIHSS profile A-E (at least PACS 
or worse) vs profile F  
3155/3505 (90.0) 97.2 12.2 25.5 93.4 32.3 
Cut-offs of scores with specificity >75% and highest possible sensitivity 
NIHSS >=14 1133/3505 (32.3) 63.1 77.2 46.1 87.1 73.9 
G-FAST=4  1029/3505 (29.4) 56.7 79.0 45.5 85.5 73.7 
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Abbreviations: 3I-SS - 3-item Stroke Scale, C-STAT - Cincinnati Stroke Triage Assessment Tool, FAST – face, arm, speech and time test, G-FAST – Go FAST score, NIHSS - National 
Institutes of Health Stroke Scale, PASS – Prehospital Acute Stroke Severity scale,  RACE  - Rapid Arterial Occlusion Evaluation Scale. 
* NIHSS>=6 is an inclusion criterion for endovascular treatment with stent retrievers according to current “AHA/ASA Focused Update of the 2013 Guidelines for the Early 
Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment”12  
C-STAT>=3 1051/3505 (30.0) 58.3 78.8 45.9 85.9 73.9 
3I-SS=3 383/3505 (10.9) 20.7 92.1 44.6 79.0 75.3 
PASS =3  689/3505 (19.7) 38.5 86.2 46.2 81.9 cc 
RACE>=6 1154/3505 (32.9) 62.2 76.1 44.5 86.7 72.8 
NIHSS profile A  793/3505 (22.6) 38.5 82.3 40.1 81.2 72.0 
NIHSS profile B 775/3505 (22.1) 37.5 82.6 40.0 81.1 72.0 
Statistically optimal cut-offs 
NIHSS >=12 1420/3505 (40.5) 72.1 69.2 42.0 88.9 69.9 
FAST=3 2207/3505 (63.0) 84.0 43.5 31.5 89.9 53.1 
G-FAST>=3 2363/3505 (67.5) 88.7 39.1 31.0 91.8 50.8 
C-STAT>=2 1461/3505 (41.7) 71.3 67.5 40.4 88.4 68.4 
3I-SS>=2 1283/3505 (36.6) 65.0 72.2 41.9 87.0 70.5 
PASS >=2 1763/3505 (50.3) 78.7 58.5 36.9 89.9  
RACE>=5 1442/3505 (41.1) 71.2 68.2 40.8 88.5 68.9 
NIHSS symptom profile A or B 1568/3505 (44.7) 75.9 64.9 40.1 89.7 67.5 
